To compare high animal protein (AP) with high plant protein (PP) diets, differing in amino acid composition, in people with type 2 diabetes (T2DM).
substantially decrease hyperglycaemia 1 and are known to induce increased satiety and postprandial thermogenesis, potential factors to control body weight, and have been reported to reduce blood pressure. 2 In epidemiological studies, high intake of red or processed meat has been associated with increased mortality, while plant protein (PP) intake was associated with reduced cardiovascular mortality. [3] [4] [5] High intake of animal protein (AP) in general has also been found to be associated with increased risk of T2DM, which was not observed with PP [6] [7] [8] ; however, whey protein intake was shown to improve meal-related metabolism in people with T2DM in several studies. 9, 10 A meta-analysis of intervention studies replacing AP with PP in people with T2DM also showed a slight improvement in glycated haemoglobin (HbA1c) by 0.15% 11 ; however, increased intake of plant products will also increase fibre and phytochemical intakes, and the differences may not relate to differences in amino acid composition of the proteins per se. 12 Typically, PP contains lower levels of the branched chain amino acids (BCAA) leucine, isoleucine and valine and of the sulphur amino acid methionine as compared with AP. 12 BCAA and higher methionine intake have been associated with insulin resistance and shortened life span 13, 14 in experimental systems, apparently because of the activation of mammalian target of rapamycin (mTOR) 15, 16 and transsulphuration 17, 18 signalling pathways. Lower levels of methionine increase the generation of hydrogen sulphide, which was reported to improve the metabolic function of adipose tissue, liver and β cells. 19 The amino acids arginine and asparagine are elevated in plant proteins (eg, legumes) 20 and arginine may improve insulin sensitivity by increasing microvascular function via nitric oxide production, 21 while asparagine shows tight links with glucose homeostasis. 22 The impact of protein consumption on kidney function is controversial and meta-analyses reported that higher amounts of protein either did not affect or deteriorated renal function. 23, 24 To our knowledge there are only two studies comparing effects of AP with PP meals on renal and glycaemic variables in people with T2DM. 25, 26 Wheeler et al. 26 reported no significant differences for glomerular filtration rate and albumin excretion rate, and HbA1c levels improved in both intervention groups. 26 In a 4-year intervention study, however, beneficial effects on renal variables were observed with PP compared with AP. 25 In both studies, the amount of protein intake was similar to normal protein consumption (0.8 g/kg body weight, 26 1.2 g/kg bodyweight) (17% of calories as protein). 25 Seeking possible explanations for the epidemiological data, we aimed to investigate whether the diverse amino acid compositions of AP and PP support the different observations. We therefore performed a clinical intervention study in people with T2DM receiving high-protein diets containing either AP or PP, which differ in their amino acid compositions, and compared the effects on insulin sensitivity, cardiovascular risk factors and renal function variables. ; liver damage; myocardial infarction or stroke within the last 6 months; psychiatric disease; acute or chronic inflammatory disease; pregnancy; food intolerance; and weight change >5 kg within the previous 3 months.
| MATERIALS AND METHODS

| Study design and participants
In the present 6-week intervention study, 44 participants with T2DM, matched for age, sex, body mass index (BMI), HbA1c and diabetes drugs, were randomized using a computer algorithm to either a high PP or high AP diet (Table S1 , Supporting Information). A total of 37 participants completed the study (AP group, n = 18; PP group, n = 19 [ Figure S1 , Supporting Information]). Total energy expenditure was estimated using the individual basal metabolic rate determined by indirect calorimetry (Vmax Encore metabolic cart; CareFusion, Yorba Linda, California) and self-reported physical activity. 28, 29 Calculated total energy expenditure was compared with mean daily calorie intake obtained from a 5-day dietary record, which the participants were asked to complete prior to the intervention. Based on this information, individual isocaloric food plans were created to maintain a constant body weight for the study participants. Participants were asked to maintain their physical activity patterns for the duration of the study.
| Dietary intervention
Participants received daily food plans to ensure an equivalent intake of high amounts of protein ( enriched with pea proteins and especially developed for this study.
Both diets contained 40% energy as carbohydrates with a low glycaemic index (GI) and 30% energy as fat, with an equal distribution of fatty acids (respectively 10% energy as saturated fatty acids, monounsaturated fatty acids and polyunsaturated fatty acids). Total restriction of AP, such as dairy products, was impractical from the point of view of participants' compliance over 6 weeks, but the AP content of the diet in the PP group was limited to 28% of total protein, while the PP content in the AP group was~20% of total protein.
To increase participants' compliance, the dietary plans were adapted to individual preferences, and participants were provided with groceries as well as detailed substitution lists for different food groups to allow variation and more flexibility. Participants were therefore able to replace foodstuffs themselves within a group. Every 2 weeks, routine measurements (blood, urine and anthropometry)
were taken, and participants received a proportion of the food from the food plans for the next 2 weeks. If there was a steady change in body weight within the intervention period, the amount of energy was adapted. The participants were advised to weigh and document all foods they had eaten, including deviations from the food plans.
Analysis of food plans was performed using PRODI 6. 
| Clinicial investigation days
Clinical investigations were conducted on the days at the beginning and at the end of the dietary intervention period. Participants arrived after an overnight fast (10 hours) on all clinical investigation days.
During the clinical investigation day, hyperinsulinaemic-euglycaemic clamps were performed at a constant insulin infusion rate of 40 mU/ kg/min for >2 hours. Steady-state conditions were defined as stable glucose infusion rates ≥30 minutes, with stable plasma glucose concentrations as described. 34 Whole-body glucose disposal [expressed as insulin-mediated glucose uptake per kg body weight (M-value)]
was calculated from the glucose infusion rate. Participants collected 24-hour urine 1 day before each clinical investigation day for determination of urea.
| Biomarkers in plasma and serum
Anthropometric data regarding abdominal, subcutaneous and liver fat and associated changes in gene expression, biomarkers and protein phosphorylation have been reported separately. 35 Blood samples were drawn and immediately chilled and centrifuged, and the super- Blood pressure was measured manually on the left upper arm after at least 3 minutes' rest. The measurement was performed 3 times and then averaged over these values.
| Statistical analysis
Data are presented as mean AE standard error of the mean (s.e.m).
Statistical significance was defined as P < .05. Non-normally distributed variables were transformed with the natural logarithm, and reassessed for normality. Changes in anthropometric and clinical blood variables were analysed using repeated-measures analysis of variance (ANOVA) for each intervention group as well as for comparison between the groups (AP vs PP), with percentage weight change as a covariate. Kidney markers in the blood were analysed using repeatedmeasures ANOVA, while urine variables were measured using Student's t-test or a non-parametric Wilcoxon's test. Non-parametric tests were performed for non-normally distributed variables. The primary outcome was insulin sensitivity (M-value). Secondary outcome analyses were considered to be exploratory, therefore, we did not perform adjustment for multiple comparisons.
The power calculation was based on a difference in the end-oftreatment M-value between the AP and PP groups of 0.30 mg/kg/ min, with a standard deviation of effect of 0.43 mg/kg/min (α = 0.05, 1 − β = 0.80), and achieved 0.99 in respect of a sample size of 37 as described. 36 The study was registered at ClincialTrials.gov (NCT02402985).
| RESULTS
| Dietary intervention
A total of 44 people volunteered for the study and 37 completed the intervention period of 6 weeks (AP group, n = 18; PP group, n = 19).
Seven participants were excluded for medical reasons or because of loss of interest or no vein access ( Figure S1 , Supporting Information).
There were no significant differences between the matched characteristics used for randomization (age, sex, BMI, HbA1c and drug treatment) at baseline (Table 1) . Recruitment was carried out and the study was conducted between June 2013 and March 2015. The experimental diets represented a major change from the food composition of the participants' usual diets before the study, with an increase in protein content of~12% of energy intake and a decrease in fat intake of 10%. Carbohydrate intake remained similar to that of the participants' habitual diets, at slightly more than 40% ( Figure 1A ,B).
In both groups, serum levels of urea increased significantly (AP group: week 0: 6.00 AE 0.27 mmol/L, week 6: 7.98 AE 0.57 mmol/L, P = .001;
PP group: week 0: 6.03 AE 0.26 mmol/L, week 6: 7.90 AE 0.30 mmol/L, P = .003; P value for AP vs PP group = .538) as a marker of protein intake, which indicated the high compliance of the participants with the food plans (Table 3 and Figure 1C Although food plans were calculated for weight maintenance, the mean BMI decreased in both groups, but without significant difference between the groups ( Table 2 ). The statistical evaluations were therefore adjusted with regard to weight changes (Table 2) .
| Glucose metabolism
The HbA1c decreased after 6 weeks in both groups by~0.5%, even though the initial HbA1c was already well controlled at~7.0%
(52.8 mmol/mol) in both groups. The difference was highly significant after the PP intervention (Table 2) . Fasting glucose decreased significantly in the AP but not in the PP group, while insulin and HOMA-IR values were not influenced by the diets. Moreover, fasting GLP-1 levels increased in both groups, but reached significance only in the PP group (Table 2) .
Whole-body insulin sensitivity improved after 6 weeks in both 
| Cardiovascular variables
Significant interactions with weight change were found for systolic blood pressure, total cholesterol, LDL cholesterol, NEFA and uric acid, therefore, adjusted values of significance were considered for those variables ( Table 2) .
Systolic blood pressure decreased slightly, but significantly, in both groups, while diastolic blood pressure decreased significantly in the PP group only, with no significant difference between the two study groups ( Table 2 ).
The diets resulted in highly significant and similar reductions in total cholesterol (by 15% and 12% in the AP and PP groups, respectively) while LDL cholesterol decreased by 16% and 11%, and HDL cholesterol by 16% and 14%, respectively (Table 2 and Figure 2A -C).
Triglycerides decreased transiently in both groups (Table 2 and Figure 2D ). Fasting NEFA decreased significantly in the PP (P = .016),
but not in the AP group (P = 1.000), and the between-group P-value was not significant (P = .425 [ Table 2 ]). Correlation analysis with previously published changes in body composition 35 showed no significant associations with reductions in blood lipids in either of the groups (data not shown).
In the AP group, CRP levels decreased significantly after 2 weeks and remained at the lower level throughout the intervention (P = .031) [ Table 2 and Figure 2E ]. Despite the high intake of protein, levels of uric acid declined in both groups, with a significant difference between the AP and PP groups (P = 3.6 × 10 −4 [ Table 2 and Figure 2F] ). 
| Renal function
Serum creatinine values did not change in the AP group, whereas they decreased in the PP group, resulting in an improved calculated eGFR (CKD-EPI [ Table 3 ]). We therefore additionally measured serum cystatin C to estimate GFR in combination with creatinine, which provided a more accurate assessment of GFR than the equation based on either of these markers alone 37 ; the eGFR remained constant after 6 weeks of high protein intake (Table 3) . Albumin excretion measured in 24-hour urine samples did not change significantly in participants without microalbuminuria and an albumin excretion rate <30 mg/24 hours at onset (AP group [n = 13]: week 0: Values are means AE s.e.m. Blood variables as well as BMI were measured at weeks 0, 2, 4, and 6. Systolic and diastolic blood pressures and the M-value obtained from hyperinsulinaemic-euglycaemic clamps were determined at week 0 and 6. Data were analysed with repeated-measures ANOVA for each intervention group, as well as for comparison between the groups (AP vs PP) using percentage weight change as a covariate in the model. Underlined values represent weight-adjusted P values for significant interaction terms between the weight change and change in variable. Significant interactions were found for systolic blood pressure, total cholesterol, LDL cholesterol, NEFA and uric acid. For non-significant interactions, the unadjusted P values were added in the table because the adjusted P values were considered as over-fitted. Values are means AE s.e.m. Levels of urea, creatinine and cystatin C were measured in blood serum samples at weeks 0, 2, 4 and 6. eGFR was determined using the CKD-EPI equation based on serum levels of creatinine and on the combination of serum levels of creatinine and cystatin C. 37 Urine excretion of urea, creatinine and albumin were detected in 24-hour urine samples at weeks 0 and 6. Statistical analysis of blood serum variables was performed with repeated-measures ANOVA for each intervention group as well as for comparison between the groups (AP vs PP). Student's t-test was used for statistical analysis of urine variables. Change of blood lipids and uric acid over 6 weeks. Levels of: A, total cholesterol; B, LDL cholesterol; C, HDL cholesterol; D, triglycerides; E, C-reactive protein; F, uric acid over 6 weeks of intervention. Black circles: AP group, black squares: PP group. Values are means AE s.e.m. *P < .05, **P < .01, ***P < .001 different from week 0 within group [n = 2]: week 0: 70.0 AE 15.0 mg/g, week 6: 27.0 AE 22.6 mg/g, P = 0.112; P value for AP vs PP group = .739).
| DISCUSSION
The PP diets were shown to reduce the incidence of T2DM and cardiovascular disease, while AP diets increased such incidences. [5] [6] [7] [8] 38 Unexpectedly, the present data showed a similar improvement in glycaemic and metabolic control in both dietary groups. Although the metabolic improvement might have been attributable to the dietary intervention and moderate weight loss per se, the absence of major differences between the AP and PP groups indicates that the protein composition did not affect the response to the intervention. The only significant difference was a greater decrease in uric acid in the AP group. The improvements in insulin sensitivity, lipid variables, CRP and uric acid, as well as hepatic fat content, 35 further underscore the metabolic benefits of both diets. No differences between the AP and PP groups were observed in the decreases in systolic blood pressure, which were significant in both groups.
The primary endpoint of the present study was the change in insulin sensitivity, which we expected to deteriorate with the AP diet as we had observed previously, possibly as a result of the increased BCAA and methionine content. 36 The intervention induced improvements in whole-body glucose disposal in the hyperinsulinaemiceuglycaemic clamps, which were unrelated to changes in body weight and body composition. Unexpectedly, the improvement in insulin sensitivity was significant only in the AP group, despite its higher BCAA content, which is thought to induce insulin resistance by activating the mTOR pathway. 13, 39 The AP diet caused greater postprandial increases in plasma levels of methionine and BCAA as compared with the PP diet, while other amino acids showed largely identical postprandial kinetics in both groups, which confirms similar digestibility of the two protein types. 35 Acute insulin resistance was shown, however, after infusion of amino acids in humans, which results in supraphysiological plasma levels and is directly related to the phosphorylation of insulin receptor substrate 1 by p70S6 protein kinase, a substrate of mTOR. 39 In addition, BCAA-induced impairment of mitochondrial function was proposed by interfering with fatty acid oxidation. 13 In the present study, we did not find increased phosphorylation of the mTOR pathway but rather a decreased phosphorylation of p70S6K in adipose tissue. 35 Thus, similarly to another recent study of high protein intake in humans, 40 we did not find evidence of increased activation of the mTOR pathway in humans. Moderate methionine restriction was related to improvements in insulin sensitivity in animal models 41, 42 ; however, improvements in insulin sensitivity were observed with both diets and thus cannot be ascribed to methionine restriction.
It has been suggested that CRP, a global marker of inflammation and an important cardiovascular risk marker, is increased by high protein intake. 43 Notably, in the present study, CRP was significantly lowered in the AP but not in the PP group. Regarding blood lipids, both diets significantly reduced LDL cholesterol by 0.4 mmol/L or 11% to 16%, even after adjustment for body weight loss, and this reduction was independent of changes in body composition, which is clinically relevant. Soy protein has previously been shown to reduce total and LDL cholesterol, 44 but a similar decrease was observed with a high AP diet in the presence of low levels of saturated fat. 45 Blood pressure decreased significantly even after correction for body weight reduction in both groups. Thus, the cardiometabolic and inflammatory profiles of both high protein diets were clearly favourable and were not dependent on protein origin and amino acid composition.
Although the diets were designed for isocaloric conditions, it
proved to be very difficult to keep body weight constant throughout the study and the BMI decreased slightly. A likely reason for this was that our healthy diets for patients with T2DM had a greater volume than the typical local Western diet with high amounts of fat and fewer vegetables and fruits. Moreover, the high protein content has also been shown to increase satiety and to reduce food intake in animal studies.
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The impact of a high protein diet on renal function in T2DM has been widely discussed, with heterogeneous conclusions. 23, 24, 26, 47, 48 In the present study, eGFR remained constant in both the AP and PP groups when using the combination of cystatin C and creatinine for calculations. Serum creatinine decreased in the PP group, in contrast to cystatin C. The synthesis of creatinine in muscle uses glycine, arginine and methionine in the form of S-adenosyl methionine as a methyl group donor, which requires~30% of the total pool of the essential amino acid methionine. 49 We interpret the change in creatinine associated with the PP diet as an indicator of changes in methionine metabolism because of decreased availability, as has been reported for vegan diets. 49 Increases in urea in the serum and urine were similar, indicating similar overall intakes of protein and similar added workload for the kidney to eliminate the urea. In addition, urinary albumin, another marker of kidney damage, decreased in both groups in participants with microalbuminuria and was unchanged in those with normo-albuminuria.
The limitations of the present study include the moderate number of participants and the restriction to white ethnicity, as well as its limited time frame. Moreover, the beneficial responses may be agerelated because the present cohort was aged >60 years and agerelated effects may play a particular role in protein intake. 50 In summary, the present study shows that high PP and AP diets allow similar short-term improvements in cardiometabolic and inflammatory variables, despite advice to maintain isocaloric and satiating food intake. High PP diets were not superior to high AP diets and only minor differences were observed, suggesting that the differences in amino acid contents do not explain metabolic responses.
The present study therefore supports the use of high AP or PP diets in the short term. In view of the unfavourable results with AP as compared to PP in epidemiological studies, [4] [5] [6] [7] [8] 11, 50 explanations targeting differences in behaviour, phytochemical content, carbohydrate and fat quality or other confounders might deserve attention.
